extract: 2026-02-01-cms-balance-model-details-rfa-design
- Factual accuracy — The claims appear factually correct, and the added evidence supports the statements made in each claim.
- Intra-PR duplicates — There are no intra-PR duplicates;…
extract: 2026-01-01-openevidence-clinical-ai-growth-12b-valuation
- Factual accuracy — The added evidence in all three claims appears factually correct, providing specific metrics and developments for OpenEvidence and its implications for AI adoption and…
extract: 2026-01-01-bvp-state-of-health-ai-2026
- Factual accuracy — The claims are factually correct, and the new evidence from the BVP report supports the assertions made in each claim.
- Intra-PR duplicates — There are no…
extract: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination
- Factual accuracy — The claims and additional evidence provided appear factually correct and are consistent with current understanding of GLP-1 receptor agonists.
- Intra-PR duplicates…
extract: 2025-10-01-variety-dropout-superfan-tier-1m-subscribers
Approved (post-rebase re-approval).
extract: 2025-06-01-abridge-valuation-growth-ai-scribe-metrics
Vida Domain Peer Review — PR #1179
Abridge valuation/growth/AI scribe metrics — 2 enrichments + 1 source archive
What This PR Does
Adds an enrichment source (Abridge Sacra analysis)…
extract: 2025-06-01-abridge-valuation-growth-ai-scribe-metrics
- Factual accuracy — The claims and entities appear factually correct, with the added evidence supporting the assertions made in the claims.
- Intra-PR duplicates — There are no…